RYOJ rYojbaba Co., Ltd. - Common Shares
NASDAQ · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Apr 8, 2026
$2.85
· of 52w range
· above low
· to high
$1.5652w low
$11.4352w high
Market Cap
$33M
P/E
285.0
EPS
$0.01
Revenue
$9M
your badges
52W Range
$2–$11
Analyst Rating
·
Price Target
·
P/E
285.0
ROE
2.8%
Net Profit Margin
1.3%
Your badge strip is empty — pin a metric anywhere on this page.
RYOJ Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$2.85
Market Cap
$33M
P/E
285.0
EPS
$0.01
Revenue
$9M
ROE
2.8%
Debt/Equity
0.7
52W Range
$2–$11
RYOJ Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$9M2023-12-31 → 2025-12-31
EPS$0.012023-12-31 → 2025-12-31
Free Cash Flow$688.5K2025-12-31 → 2025-12-31
Net margin1.3%2025-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | RYOJ | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | 285.0 | · | · | · | |
| P/S | 3.5 | · | · | · | |
| P/B | 5.4 | · | · | · | |
| EV / EBITDA | -105.1 | · | · | · | |
| Price / FCF | 47.8 | · | · | · | |
| Price / Cash Flow | 38.1 | · | · | · | |
| EV / Revenue | 3.3 | · | · | · | |
| EV / FCF | 44.9 | · | · | · | |
| Price / Tangible Book | 6.6 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | RYOJ | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin | 26.6% | · | · | · | |
| Operating Margin | -8.1% | · | · | · | |
| EBITDA Margin | -3.1% | · | · | · | |
| Pretax Margin | -5.0% | · | · | · | |
| Net Profit Margin | 1.3% | · | · | · | |
| ROA | 0.72% | · | · | · | |
| ROE | 2.8% | · | · | · | |
| ROIC | 1.9% | · | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | RYOJ | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity | 0.7 | · | · | · | |
| Current Ratio | 2.7 | · | · | · | |
| Quick Ratio | 2.5 | · | · | · | |
| Long-Term Debt / Equity | 0.5 | · | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | RYOJ | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.6 | · | · | · | |
| Inventory Turnover | 98.9 | · | · | · | |
| Receivables Turnover | 4.9 | · | · | · | |
| Revenue / Employee | ≈$72.9K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $9M | $12M | $11M | |
| Cost of Revenue | $7M | $7M | $7M | |
| Gross Profit | $2M | $4M | $4M | |
| SG&A Expense | $2M | $2M | $2M | |
| Operating Expenses | $3M | $3M | $2M | |
| Operating Income | $-755.4K | $2M | $1M | |
| Interest Income | $4.3K | $322 | $12.8K | |
| Other Non-op | $290.0K | $82.5K | $81.7K | |
| Pretax Income | $-465.4K | $2M | $1M | |
| Income Tax | $-584.8K | $611.0K | $616.4K | |
| Net Income | $119.4K | $1M | $770.6K | |
| EPS (Basic) | $0.01 | $0.13 | $0.08 | |
| EPS (Diluted) | $0.01 | $0.13 | $0.08 | |
| Shares (Basic) | 10,505,755 | 10,000,000 | 10,000,000 | |
| Shares (Diluted) | 10,505,755 | 10,000,000 | 10,000,000 | |
| EBITDA | $-294.0K | · | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $6M | $3M | · | |
| Receivables | $1M | $3M | · | |
| Inventory | $72.5K | $66.0K | · | |
| Prepaid Expense | $440.9K | $90.4K | · | |
| Current Assets | $8M | $6M | · | |
| PP&E (Net) | $1M | $2M | · | |
| PP&E (Gross) | $3M | $3M | · | |
| Accum. Depreciation | $2M | $1M | · | |
| Intangibles | $1M | $2M | · | |
| Other Non-current Assets | $8.3K | $10.4K | · | |
| Total Assets | $17M | $16M | · | |
| Accounts Payable | $614.3K | $1M | · | |
| Accrued Liabilities | $21.0K | $12.7K | · | |
| Short-term Debt | $319.4K | · | · | |
| Current Liabilities | $3M | $5M | · | |
| Capital Leases | $4M | $5M | · | |
| Other Non-current Liabilities | $101.5K | $106.2K | · | |
| Total Liabilities | $11M | $14M | · | |
| Long-term Debt | $4M | $5M | · | |
| Total Debt | $4M | · | · | |
| Common Stock | $3M | $41.5K | · | |
| Retained Earnings | $2M | $2M | · | |
| AOCI | $-738.6K | $-497.8K | · | |
| Stockholders' Equity | $6M | $3M | $1M | |
| Liabilities + Equity | $17M | $16M | · | |
| Shares Outstanding | 11,550,000 | 10,000,000 | 10,000,000 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $461.5K | $469.3K | $333.6K | |
| Stock-based Comp | $537.0K | · | · | |
| Deferred Tax | $-587.2K | $5.3K | $224.9K | |
| Amort. of Intangibles | $234.0K | $230.8K | $83.0K | |
| Other Non-cash | $333.3K | · | · | |
| Operating Cash Flow | $863.9K | $802.4K | $389.0K | |
| CapEx | $175.4K | $121.2K | $70.3K | |
| Investing Cash Flow | $-175.4K | $-121.2K | $625.6K | |
| Debt Issued | · | · | $559.3K | |
| Net Debt Issued | $-1M | · | · | |
| Financing Cash Flow | $3M | $-2M | $-1M | |
| Net Change in Cash | $4M | $-2M | $-657.5K | |
| Taxes Paid | $696.0K | $297.9K | $321.2K | |
| Free Cash Flow | $688.5K | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Gross Margin | 26.6% | · | · | |
| Operating Margin | -8.1% | · | · | |
| Net Margin | 1.3% | · | · | |
| Pretax Margin | -5.0% | · | · | |
| EBITDA Margin | -3.1% | · | · | |
| ROA | 0.72% | · | · | |
| ROE | 2.8% | · | · | |
| ROIC | 1.9% | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 2.7 | · | · | |
| Quick Ratio | 2.5 | · | · | |
| Debt / Equity | 0.7 | · | · | |
| LT Debt / Equity | 0.5 | · | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.6 | · | · | |
| Inventory Turnover | 98.9 | · | · | |
| Receivables Turnover | 4.9 | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Book Value / Share | $0.53 | · | · | |
| Revenue / Share | $0.89 | · | · | |
| Cash Flow / Share | $0.08 | · | · | |
| Cash / Share | $0.53 | · | · | |
| EPS (TTM) | $0.01 | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $9M | · | · | |
| Net Income TTM | $119.4K | · | · | |
| Market Cap | $35M | · | · | |
| Enterprise Value | $33M | · | · | |
| P/E | 305.0 | · | · | |
| P/S | 3.8 | · | · | |
| P/B | 5.8 | · | · | |
| P / Tangible Book | 7.1 | · | · | |
| P / Cash Flow | 40.8 | · | · | |
| P / FCF | 51.2 | · | · | |
| EV / EBITDA | -113.0 | · | · | |
| EV / FCF | 48.2 | · | · | |
| EV / Revenue | 3.6 | · | · | |
| Earnings Yield | 0.33% | · | · |
Per Share
| Metric | Trend | Q4 2025 |
|---|---|---|
| EPS (TTM) | $0.01 |
Valuation (TTM)
| Metric | Trend | Q4 2025 |
|---|---|---|
| Revenue TTM | $9M | |
| Net Income TTM | $119.4K | |
| P/E | 305.0 | |
| Earnings Yield | 0.33% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenue | $9M | $12M | $11M |
| Gross Margin % | 26.6% | · | · |
| Operating Margin % | -8.1% | · | · |
| Net Income | $119.4K | $1M | $770.6K |
| Diluted EPS | $0.01 | $0.13 | $0.08 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Debt / Equity | 0.7 | · | · |
| Current Ratio | 2.7 | · | · |
| Quick Ratio | 2.5 | · | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Free Cash Flow | $688.5K | · | · |
Institutional owners (13F) 3 filers · $247 total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
3
Value held
$247
New positions
0
Exited positions
0
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 0 (-1 vs prior Q) | 0 (-1 vs prior Q) | 2 (+1 vs prior Q) | 1 (0 vs prior Q) | -4K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| JPMORGAN CHASE & CO | $160 | 63 | 64.78% | Shares |
| UBS Group AG | $64 | 25 | 25.91% | Shares |
| Caitong International Asset Management Co., Ltd | $23 | 9 | 9.31% | Shares |
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Ryoji Baba, Miracle Exploration Technologies Ltd. | Aug. 20, 2025 | 71.32% | Initial filing | · | SEC |
| Satoshi Saito | Aug. 20, 2025 | 5.69% | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F/A filed Apr 8, 2026